Table 4.
Factor | 5 yr1 | 10 yr1 |
Breast cancer survival | ||
Treatment | ||
Tamoxifen | 0.94 | 0.85 |
Tamoxifen + Octreotide LAR | 0.94 | 0.85 |
Tumour size | ||
T1 | 0.96 | 0.89 |
≥ T2, unknown | 0.90 | 0.78 |
Nodal status | ||
N0 | 0.96 | 0.89 |
N1, N2, Nx | 0.90 | 0.78 |
Other cause survival | ||
Treatment | ||
Tamoxifen | 0.98 | 0.94 |
Tamoxifen + Octreotide LAR | 0.99 | 0.95 |
Age | ||
60 | 0.99 | 0.95 |
70 | 0.97 | 0.90 |
BMI | ||
25 | 0.99 | 0.96 |
30 | 0.98 | 0.94 |
35 | 0.98 | 0.91 |
40 | 0.97 | 0.88 |
45 | 0.95 | 0.84 |
Survival for is adjusted for the effects of other factors: treatment, stratification and other significant factors.